Concepts (222)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Radiopharmaceuticals | 9 | 2023 | 62 | 1.730 |
Why?
|
| Technetium | 5 | 2018 | 11 | 1.690 |
Why?
|
| Chelating Agents | 7 | 2023 | 52 | 1.650 |
Why?
|
| Lanthanoid Series Elements | 7 | 2011 | 8 | 1.470 |
Why?
|
| Oligopeptides | 4 | 2018 | 109 | 1.350 |
Why?
|
| Rhenium | 4 | 2018 | 12 | 1.340 |
Why?
|
| Pyridones | 4 | 2023 | 50 | 1.200 |
Why?
|
| Tungsten Compounds | 12 | 2016 | 16 | 1.130 |
Why?
|
| Coordination Complexes | 5 | 2019 | 28 | 1.120 |
Why?
|
| Radioisotopes | 6 | 2020 | 17 | 1.090 |
Why?
|
| Zirconium | 3 | 2015 | 11 | 0.990 |
Why?
|
| Alpha Particles | 3 | 2020 | 4 | 0.950 |
Why?
|
| Europium | 5 | 2011 | 9 | 0.770 |
Why?
|
| Positron-Emission Tomography | 6 | 2023 | 93 | 0.760 |
Why?
|
| Organotechnetium Compounds | 6 | 2007 | 9 | 0.700 |
Why?
|
| Radiochemistry | 5 | 2020 | 6 | 0.690 |
Why?
|
| Oxides | 2 | 2012 | 100 | 0.680 |
Why?
|
| Actinium | 1 | 2020 | 1 | 0.670 |
Why?
|
| Magnetic Resonance Spectroscopy | 13 | 2016 | 301 | 0.660 |
Why?
|
| Tissue Distribution | 10 | 2018 | 240 | 0.590 |
Why?
|
| Mice, Nude | 6 | 2018 | 408 | 0.570 |
Why?
|
| Spermine | 2 | 2019 | 67 | 0.560 |
Why?
|
| Neoplasms | 3 | 2020 | 1377 | 0.490 |
Why?
|
| Deferoxamine | 1 | 2015 | 17 | 0.480 |
Why?
|
| Immunoconjugates | 1 | 2015 | 8 | 0.480 |
Why?
|
| Electrons | 2 | 2012 | 76 | 0.440 |
Why?
|
| Breast | 1 | 2015 | 139 | 0.430 |
Why?
|
| Holmium | 1 | 2013 | 1 | 0.420 |
Why?
|
| Radioimmunotherapy | 1 | 2013 | 5 | 0.420 |
Why?
|
| Melanoma, Experimental | 1 | 2013 | 13 | 0.420 |
Why?
|
| Acetonitriles | 2 | 2011 | 10 | 0.420 |
Why?
|
| Models, Molecular | 9 | 2016 | 876 | 0.410 |
Why?
|
| Sodium Pertechnetate Tc 99m | 1 | 2011 | 1 | 0.360 |
Why?
|
| Antibodies, Monoclonal | 1 | 2013 | 306 | 0.360 |
Why?
|
| Light | 2 | 2011 | 185 | 0.350 |
Why?
|
| Molecular Structure | 8 | 2019 | 570 | 0.350 |
Why?
|
| Melanins | 1 | 2011 | 42 | 0.350 |
Why?
|
| Animals | 18 | 2023 | 16992 | 0.320 |
Why?
|
| Melanoma | 1 | 2011 | 110 | 0.320 |
Why?
|
| Crystallography, X-Ray | 8 | 2007 | 280 | 0.320 |
Why?
|
| Isotope Labeling | 6 | 2018 | 26 | 0.300 |
Why?
|
| Mice | 8 | 2023 | 6644 | 0.300 |
Why?
|
| Ligands | 6 | 2023 | 388 | 0.280 |
Why?
|
| Metal Nanoparticles | 1 | 2011 | 230 | 0.280 |
Why?
|
| Oxidation-Reduction | 5 | 2012 | 457 | 0.280 |
Why?
|
| Receptors, Somatostatin | 1 | 2007 | 3 | 0.270 |
Why?
|
| Somatostatin | 1 | 2007 | 20 | 0.270 |
Why?
|
| Oxygen | 1 | 2007 | 218 | 0.240 |
Why?
|
| Technetium Compounds | 2 | 2016 | 3 | 0.240 |
Why?
|
| Amino Acid Sequence | 3 | 2018 | 1180 | 0.240 |
Why?
|
| Molecular Conformation | 7 | 2016 | 155 | 0.230 |
Why?
|
| Cell Line, Tumor | 4 | 2015 | 2676 | 0.220 |
Why?
|
| Peptides, Cyclic | 1 | 2004 | 29 | 0.210 |
Why?
|
| Breast Neoplasms | 1 | 2015 | 1723 | 0.210 |
Why?
|
| Drug Stability | 2 | 2014 | 129 | 0.200 |
Why?
|
| Vanadium | 3 | 2016 | 6 | 0.200 |
Why?
|
| Electrochemistry | 3 | 2012 | 38 | 0.200 |
Why?
|
| Hydrogen-Ion Concentration | 4 | 2020 | 388 | 0.190 |
Why?
|
| Female | 11 | 2018 | 24698 | 0.190 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 2 | 2019 | 16 | 0.190 |
Why?
|
| Radionuclide Imaging | 5 | 2011 | 29 | 0.180 |
Why?
|
| Thorium | 1 | 2020 | 2 | 0.170 |
Why?
|
| Peptides | 1 | 2004 | 372 | 0.170 |
Why?
|
| Pistacia | 1 | 2020 | 3 | 0.160 |
Why?
|
| Radiation Monitoring | 1 | 2020 | 9 | 0.160 |
Why?
|
| Transition Elements | 1 | 2019 | 3 | 0.160 |
Why?
|
| Solvents | 2 | 2010 | 113 | 0.150 |
Why?
|
| Stereoisomerism | 3 | 2007 | 169 | 0.140 |
Why?
|
| Polymers | 3 | 2008 | 155 | 0.140 |
Why?
|
| Water | 4 | 2011 | 316 | 0.130 |
Why?
|
| Cyclooctanes | 1 | 2016 | 1 | 0.130 |
Why?
|
| Lutetium | 1 | 2016 | 3 | 0.130 |
Why?
|
| Anions | 4 | 2010 | 44 | 0.120 |
Why?
|
| Phosphorus Isotopes | 5 | 2007 | 8 | 0.120 |
Why?
|
| Tetrazoles | 1 | 2016 | 46 | 0.120 |
Why?
|
| Humans | 14 | 2020 | 43102 | 0.120 |
Why?
|
| Bone and Bones | 1 | 2016 | 114 | 0.120 |
Why?
|
| Isomerism | 2 | 2016 | 64 | 0.120 |
Why?
|
| Emollients | 1 | 2015 | 1 | 0.120 |
Why?
|
| Skin Diseases | 1 | 2015 | 30 | 0.110 |
Why?
|
| Benzyl Compounds | 1 | 1994 | 3 | 0.110 |
Why?
|
| X-Ray Absorption Spectroscopy | 2 | 2013 | 7 | 0.110 |
Why?
|
| Methane | 1 | 2014 | 12 | 0.110 |
Why?
|
| Pentetic Acid | 1 | 2013 | 4 | 0.110 |
Why?
|
| Yttrium Radioisotopes | 1 | 2013 | 4 | 0.110 |
Why?
|
| Photochemistry | 2 | 2011 | 57 | 0.100 |
Why?
|
| Half-Life | 1 | 2013 | 63 | 0.100 |
Why?
|
| Imidazoles | 1 | 2014 | 142 | 0.100 |
Why?
|
| Sulfuric Acids | 1 | 2013 | 4 | 0.100 |
Why?
|
| Methanol | 1 | 2013 | 22 | 0.100 |
Why?
|
| Radioactive Waste | 1 | 2012 | 4 | 0.100 |
Why?
|
| Chemistry, Physical | 3 | 2008 | 50 | 0.090 |
Why?
|
| Quantum Theory | 1 | 2012 | 79 | 0.090 |
Why?
|
| Thermodynamics | 1 | 2012 | 229 | 0.090 |
Why?
|
| Phenanthrolines | 1 | 2011 | 4 | 0.090 |
Why?
|
| Quaternary Ammonium Compounds | 1 | 2011 | 33 | 0.090 |
Why?
|
| Amines | 1 | 2011 | 41 | 0.080 |
Why?
|
| Salts | 1 | 2010 | 18 | 0.080 |
Why?
|
| Solutions | 1 | 2010 | 65 | 0.080 |
Why?
|
| Ions | 1 | 2010 | 71 | 0.080 |
Why?
|
| Electrochemical Techniques | 1 | 2010 | 32 | 0.080 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2011 | 184 | 0.080 |
Why?
|
| Pyridines | 1 | 2011 | 139 | 0.080 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2011 | 347 | 0.080 |
Why?
|
| Radioligand Assay | 2 | 2007 | 65 | 0.080 |
Why?
|
| Chemical Phenomena | 3 | 2002 | 56 | 0.080 |
Why?
|
| Organometallic Compounds | 2 | 2007 | 71 | 0.070 |
Why?
|
| Drug Delivery Systems | 1 | 2011 | 277 | 0.070 |
Why?
|
| Luminescence | 3 | 2005 | 31 | 0.070 |
Why?
|
| Yttrium | 1 | 2008 | 3 | 0.070 |
Why?
|
| Silicon Compounds | 1 | 2008 | 7 | 0.070 |
Why?
|
| Porphyrins | 2 | 2008 | 57 | 0.070 |
Why?
|
| Rats | 6 | 2007 | 3735 | 0.070 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 2004 | 465 | 0.070 |
Why?
|
| Magnetics | 1 | 2007 | 43 | 0.070 |
Why?
|
| Electron Spin Resonance Spectroscopy | 1 | 2007 | 41 | 0.070 |
Why?
|
| Circular Dichroism | 1 | 2007 | 64 | 0.070 |
Why?
|
| Neoplasm Transplantation | 1 | 2007 | 129 | 0.070 |
Why?
|
| Rubella | 1 | 1986 | 16 | 0.060 |
Why?
|
| Silicon Dioxide | 1 | 2005 | 39 | 0.060 |
Why?
|
| Spectrophotometry, Infrared | 3 | 2006 | 31 | 0.060 |
Why?
|
| Adsorption | 2 | 2020 | 74 | 0.060 |
Why?
|
| Phosphotungstic Acid | 1 | 2004 | 1 | 0.060 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 1986 | 117 | 0.060 |
Why?
|
| Pancreatic Neoplasms | 1 | 2007 | 218 | 0.050 |
Why?
|
| Models, Biological | 1 | 2007 | 712 | 0.050 |
Why?
|
| Kinetics | 2 | 2020 | 695 | 0.050 |
Why?
|
| Chromans | 1 | 2001 | 16 | 0.050 |
Why?
|
| Pyrrolidines | 1 | 2001 | 31 | 0.040 |
Why?
|
| Metals, Rare Earth | 1 | 2001 | 3 | 0.040 |
Why?
|
| Piperidines | 1 | 2001 | 83 | 0.040 |
Why?
|
| Structure-Activity Relationship | 3 | 2016 | 506 | 0.040 |
Why?
|
| Solubility | 3 | 2006 | 139 | 0.040 |
Why?
|
| Nicotinic Agonists | 1 | 2001 | 88 | 0.040 |
Why?
|
| Uranium | 1 | 2020 | 24 | 0.040 |
Why?
|
| X-Ray Diffraction | 3 | 2005 | 66 | 0.040 |
Why?
|
| Seawater | 1 | 2020 | 54 | 0.040 |
Why?
|
| Heart | 2 | 1992 | 184 | 0.040 |
Why?
|
| Beta Particles | 1 | 2018 | 2 | 0.040 |
Why?
|
| Anisotropy | 2 | 2007 | 33 | 0.030 |
Why?
|
| Mineral Oil | 1 | 2015 | 1 | 0.030 |
Why?
|
| Pruritus | 1 | 2015 | 4 | 0.030 |
Why?
|
| Petrolatum | 1 | 2015 | 2 | 0.030 |
Why?
|
| Erythema | 1 | 2015 | 10 | 0.030 |
Why?
|
| Cations | 2 | 2006 | 50 | 0.030 |
Why?
|
| Glycerol | 1 | 2015 | 34 | 0.030 |
Why?
|
| Spectroscopy, Fourier Transform Infrared | 2 | 2005 | 83 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 1 | 2016 | 694 | 0.030 |
Why?
|
| Dicarboxylic Acids | 1 | 1993 | 1 | 0.030 |
Why?
|
| Diamide | 1 | 1993 | 2 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2016 | 1124 | 0.020 |
Why?
|
| Sulfhydryl Compounds | 1 | 1993 | 51 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2015 | 719 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 2 | 1994 | 1766 | 0.020 |
Why?
|
| Piperazines | 1 | 1992 | 120 | 0.020 |
Why?
|
| Gallium Radioisotopes | 1 | 1990 | 3 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2015 | 1604 | 0.020 |
Why?
|
| Italy | 2 | 1989 | 27 | 0.020 |
Why?
|
| Aged, 80 and over | 2 | 2015 | 2853 | 0.020 |
Why?
|
| Male | 7 | 2015 | 23409 | 0.020 |
Why?
|
| Fibroma | 1 | 1988 | 4 | 0.020 |
Why?
|
| Mesentery | 1 | 1988 | 9 | 0.020 |
Why?
|
| Pharmaceutical Solutions | 1 | 2008 | 5 | 0.020 |
Why?
|
| Peritoneal Neoplasms | 1 | 1988 | 18 | 0.020 |
Why?
|
| Absorption | 1 | 2008 | 22 | 0.020 |
Why?
|
| Scattering, Radiation | 1 | 2008 | 43 | 0.020 |
Why?
|
| Luminescent Measurements | 1 | 2008 | 26 | 0.020 |
Why?
|
| Lasers | 1 | 2008 | 57 | 0.020 |
Why?
|
| Temperature | 2 | 2008 | 313 | 0.020 |
Why?
|
| Static Electricity | 1 | 2008 | 86 | 0.020 |
Why?
|
| Rubella Vaccine | 1 | 1986 | 2 | 0.020 |
Why?
|
| Epidemiologic Methods | 1 | 1986 | 56 | 0.020 |
Why?
|
| Immune System | 1 | 1986 | 41 | 0.020 |
Why?
|
| Brain | 1 | 1994 | 1472 | 0.020 |
Why?
|
| Aluminum Silicates | 1 | 2005 | 7 | 0.010 |
Why?
|
| Chromatography, Gel | 1 | 2005 | 51 | 0.010 |
Why?
|
| Indicators and Reagents | 1 | 2005 | 61 | 0.010 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2006 | 102 | 0.010 |
Why?
|
| Microscopy, Atomic Force | 1 | 2005 | 61 | 0.010 |
Why?
|
| Disease Outbreaks | 1 | 1986 | 175 | 0.010 |
Why?
|
| Surface Properties | 1 | 2005 | 160 | 0.010 |
Why?
|
| Spectrum Analysis, Raman | 1 | 2005 | 95 | 0.010 |
Why?
|
| Aged | 2 | 2015 | 8214 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2006 | 611 | 0.010 |
Why?
|
| Middle Aged | 3 | 2015 | 12222 | 0.010 |
Why?
|
| Drug Design | 1 | 2005 | 186 | 0.010 |
Why?
|
| Colorectal Neoplasms | 1 | 1989 | 512 | 0.010 |
Why?
|
| Synaptosomes | 1 | 2001 | 23 | 0.010 |
Why?
|
| Macaca fascicularis | 2 | 1993 | 65 | 0.010 |
Why?
|
| Xenopus laevis | 1 | 2001 | 73 | 0.010 |
Why?
|
| Acetylcholine | 1 | 2001 | 77 | 0.010 |
Why?
|
| Rats, Inbred Strains | 2 | 1992 | 126 | 0.010 |
Why?
|
| Spectrophotometry | 1 | 2001 | 63 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 2001 | 314 | 0.010 |
Why?
|
| Oocytes | 1 | 2001 | 149 | 0.010 |
Why?
|
| Receptors, Nicotinic | 1 | 2001 | 114 | 0.010 |
Why?
|
| Pregnancy | 1 | 1986 | 1772 | 0.010 |
Why?
|
| Corpus Striatum | 1 | 2001 | 121 | 0.010 |
Why?
|
| Dopamine | 1 | 2001 | 275 | 0.010 |
Why?
|
| Cerebral Cortex | 1 | 2001 | 306 | 0.010 |
Why?
|
| Nicotine | 1 | 2001 | 302 | 0.010 |
Why?
|
| Adolescent | 1 | 1986 | 6081 | 0.010 |
Why?
|
| Adult | 2 | 1989 | 13872 | 0.010 |
Why?
|
| Blood Proteins | 1 | 1993 | 77 | 0.010 |
Why?
|
| Perfusion | 1 | 1992 | 38 | 0.010 |
Why?
|
| Sulfur | 1 | 1992 | 22 | 0.010 |
Why?
|
| Diagnostic Imaging | 1 | 1992 | 53 | 0.010 |
Why?
|
| Nitrogen | 1 | 1992 | 84 | 0.010 |
Why?
|
| Tomography, Emission-Computed | 1 | 1990 | 13 | 0.010 |
Why?
|
| Cysteamine | 1 | 1990 | 4 | 0.010 |
Why?
|
| Kidney | 1 | 1993 | 372 | 0.010 |
Why?
|
| Radiography | 1 | 1989 | 71 | 0.000 |
Why?
|
| Occult Blood | 1 | 1989 | 32 | 0.000 |
Why?
|
| Biopsy | 1 | 1989 | 177 | 0.000 |
Why?
|
| Colonoscopy | 1 | 1989 | 122 | 0.000 |
Why?
|
| Colon | 1 | 1989 | 120 | 0.000 |
Why?
|
| Fibrosis | 1 | 1988 | 169 | 0.000 |
Why?
|
| Neoplasm Staging | 1 | 1989 | 374 | 0.000 |
Why?
|
| Mass Screening | 1 | 1989 | 541 | 0.000 |
Why?
|
| Retrospective Studies | 1 | 1989 | 2544 | 0.000 |
Why?
|
| Risk Factors | 1 | 1989 | 3994 | 0.000 |
Why?
|
| Chemistry | 1 | 1972 | 15 | 0.000 |
Why?
|